Skip to Main content Skip to Navigation
Journal articles

Inhibiting the HIV integration process: past, present, and the future.

Abstract : HIV integrase (IN) catalyzes the insertion into the genome of the infected human cell of viral DNA produced by the retrotranscription process. The discovery of raltegravir validated the existence of the IN, which is a new target in the field of anti-HIV drug research. The mechanism of catalysis of IN is depicted, and the characteristics of the inhibitors of the catalytic site of this viral enzyme are reported. The role played by the resistance is elucidated, as well as the possibility of bypassing this problem. New approaches to block the integration process are depicted as future perspectives, such as development of allosteric IN inhibitors, dual inhibitors targeting both IN and other enzymes, inhibitors of enzymes that activate IN, activators of IN activity, as well as a gene therapy approach.
Document type :
Journal articles
Complete list of metadatas

Cited literature [138 references]  Display  Hide  Download

https://hal-riip.archives-ouvertes.fr/pasteur-00968857
Contributor : Istituto Pasteur Fondazione Cenci Bolognetti <>
Submitted on : Tuesday, April 1, 2014 - 4:27:02 PM
Last modification on : Wednesday, October 10, 2018 - 3:46:02 PM
Long-term archiving on: : Monday, April 10, 2017 - 8:18:36 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Roberto Di Santo. Inhibiting the HIV integration process: past, present, and the future.. Journal of Medicinal Chemistry, American Chemical Society, 2014, 57 (3), pp.539-66. ⟨10.1021/jm400674a⟩. ⟨pasteur-00968857⟩

Share

Metrics

Record views

112